HuGE Literature Finder
|
||
Records 1-89
|
Using topic modeling via non-negative matrix factorization to identify relationships between genetic variants and disease phenotypes: A case study of Lipoprotein(a) (LPA).
PloS one 2019 14 (2): e0212112. Zhao Juan, Feng QiPing, Wu Patrick, Warner Jeremy L, Denny Joshua C, Wei Wei- |
|
Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries.
Nature communications 2018 Jul 9 (1): 2606. Zekavat Seyedeh M, Ruotsalainen Sanni, Handsaker Robert E, Alver Maris, Bloom Jonathan, Poterba Timothy, Seed Cotton, Ernst Jason, Chaffin Mark, Engreitz Jesse, Peloso Gina M, Manichaikul Ani, Yang Chaojie, Ryan Kathleen A, Fu Mao, Johnson W Craig, Tsai Michael, Budoff Matthew, Ramachandran Vasan S, Cupples L Adrienne, Rotter Jerome I, Rich Stephen S, Post Wendy, Mitchell Braxton D, Correa Adolfo, Metspalu Andres, Wilson James G, Salomaa Veikko, Kellis Manolis, Daly Mark J, Neale Benjamin M, McCarroll Steven, Surakka Ida, Esko Tonu, Ganna Andrea, Ripatti Samuli, Kathiresan Sekar, Natarajan Pradeep, |
|
LPA
Gene Polymorphisms and Gene Expression Associated with Coronary Artery Disease.
BioMed research international 2017 2017 4138376. Song Zi-Kai, Cao Hong-Yan, Wu Hai-Di, Zhou Li-Ting, Qin Li |
|
SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a).
Circulation. Cardiovascular genetics 2016 Oct 9 (5): 408-418. Yang Xiaoping, Sethi Amar, Yanek Lisa R, Knapper Cathy, Nordestgaard Børge G, Tybjærg-Hansen Anne, Becker Diane M, Mathias Rasika A, Remaley Alan T, Becker Lewis |
|
Serum lipoprotein(a) level as long-term predictor of cardiovascular mortality in a large sample of subjects in primary cardiovascular prevention: data from the Brisighella Heart Study.
European journal of internal medicine 2016 Aug . Fogacci Federica, Cicero Arrigo Francesco Giuseppe, D'Addato Sergio, D'Agostini Laura, Rosticci Martina, Giovannini Marina, Bertagnin Enrico, Borghi Claudio, |
|
Functional Variant in the SLC22A3-LPAL2-LPA Gene Cluster Contributes to the Severity of Coronary Artery Disease.
Arteriosclerosis, thrombosis, and vascular biology 2016 Jul . Wang Long, Chen Juan, Zeng Ying, Wei Jie, Jing Jinjin, Li Ge, Su Li, Tang Xiaojun, Wu Tangchun, Zhou |
|
Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apo(a) Characterization.
Arteriosclerosis, thrombosis, and vascular biology 2016 Jul . Roeseler Eberhard, Julius Ulrich, Heigl Franz, Spitthoever Ralf, Heutling Dennis, Breitenberger Paul, Leebmann Josef, Lehmacher Walter, Kamstrup Pia R, Nordestgaard Børge G, Maerz Winfried, Noureen Asma, Schmidt Konrad, Kronenberg Florian, Heibges Andreas, Klingel Reinhard, |
|
Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease.
Journal of internal medicine 2016 May . Nsaibia M J, Mahmut A, Boulanger M-C, Arsenault B J, Bouchareb R, Simard S, Witztum J L, Clavel M-A, Pibarot P, Bossé Y, Tsimikas S, Mathieu |
|
Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2016 Feb . Kronenberg Flori |
|
Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease.
European heart journal cardiovascular Imaging 2016 Jan . Hojo Yoshiaki, Kumakura Hisao, Kanai Hiroyoshi, Iwasaki Toshiya, Ichikawa Shuichi, Kurabayashi Masahi |
|
Searching for a common mechanism for placenta-mediated pregnancy complications and cardiovascular disease: role of lipoprotein(a).
Fertility and sterility 2016 Jan . Romagnuolo Ilaria, Sticchi Elena, Attanasio Monica, Grifoni Elisa, Cioni Gabriele, Cellai Anna Paola, Abbate Rosanna, Fatini Cinz |
|
Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism.
PloS one 2016 11 (2): e0149427. Sticchi Elena, Magi Alberto, Kamstrup Pia R, Marcucci Rossella, Prisco Domenico, Martinelli Ida, Mannucci Pier Mannuccio, Abbate Rosanna, Giusti Bet |
|
Sex-Specific Genetic Variants are Associated With Coronary Endothelial Dysfunction.
Journal of the American Heart Association 2016 5 (4): . Yoshino Satoshi, Cilluffo Rebecca, Prasad Megha, Best Patricia J M, Atkinson Elizabeth J, Aoki Tatsuo, Cunningham Julie M, de Andrade Mariza, Lerman Lilach O, Lerman Am |
|
Elevated Lipoprotein(a) Levels, LPA Risk Genotypes, and Increased Risk of Heart Failure in the General Population.
JACC. Heart failure 2015 Nov . Kamstrup Pia R, Nordestgaard Børge |
|
Lack of association of rs3798220 with small apolipoprotein(a) isoforms and high lipoprotein(a) levels in East and Southeast Asians.
Atherosclerosis 2015 Oct 242 (2): 521-8. Khalifa Mahmoud, Noureen Asma, Ertelthalner Kathrin, Bandegi Ahmad Reza, Delport Rhena, Firdaus Wance J J, Geethanjali Finney S, Luthra Kalpana, Makemaharn Orawan, Pang Richard W C, Salem Abdel-Halim, Sasaki Jun, Schiefenhoevel Wulf, Lingenhel Arno, Kronenberg Florian, Utermann Gerd, Schmidt Konr |
Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study.
Journal of human genetics 2015 Sep . Li Jin, Lange Leslie A, Sabourin Jeremy, Duan Qing, Valdar William, Willis Monte S, Li Yun, Wilson James G, Lange Ethan |
|
Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia.
Journal of internal medicine 2015 Aug 278 (2): 166-73. Vongpromek R, Bos S, Ten Kate G-J R, Yahya R, Verhoeven A J M, de Feyter P J, Kronenberg F, Roeters van Lennep J E, Sijbrands E J G, Mulder M |
|
Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels.
Human molecular genetics 2015 Apr 24 (8): 2390-400. Lu Wensheng, Cheng Yu-Ching, Chen Keping, Wang Hong, Gerhard Glenn S, Still Christopher D, Chu Xin, Yang Rongze, Parihar Ankita, O'Connell Jeffrey R, Pollin Toni I, Angles-Cano Eduardo, Quon Michael J, Mitchell Braxton D, Shuldiner Alan R, Fu M |
|
Association of a methylene tetrahydrofolate reductase C677T polymorphism with several blood chemical levels in a Chinese population.
Genetic testing and molecular biomarkers 2015 Jan 19 (1): 24-9. Wen Can, Lv Jiao-Feng, Wang Ling, Zhu Wei-Feng, Wan Fu-Sheng, Wang Xiao-Zho |
|
Low "quotient" Lp(a) concentration mediates autoimmune activation and independently predicts cardiometabolic risk.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2015 Jan 123 (1): 11-8. Onat A, Çoban N, Can G, Yüksel M, Karagöz A, Yüksel H, Ademo?lu E, Erginel-Ünaltuna |
|
A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk.
Arteriosclerosis, thrombosis, and vascular biology 2014 Sep 34 (9): 2095-9. Kyriakou Theodosios, Seedorf Udo, Goel Anuj, Hopewell Jemma C, Clarke Robert, Watkins Hugh, Farrall Martin, |
|
Distribution and medical impact of loss-of-function variants in the Finnish founder population.
PLoS genetics 2014 Jul 10 (7): e1004494. Lim Elaine T, Würtz Peter, Havulinna Aki S, Palta Priit, Tukiainen Taru, Rehnström Karola, Esko Tõnu, Mägi Reedik, Inouye Michael, Lappalainen Tuuli, Chan Yingleong, Salem Rany M, Lek Monkol, Flannick Jason, Sim Xueling, Manning Alisa, Ladenvall Claes, Bumpstead Suzannah, Hämäläinen Eija, Aalto Kristiina, Maksimow Mikael, Salmi Marko, Blankenberg Stefan, Ardissino Diego, Shah Svati, Horne Benjamin, McPherson Ruth, Hovingh Gerald K, Reilly Muredach P, Watkins Hugh, Goel Anuj, Farrall Martin, Girelli Domenico, Reiner Alex P, Stitziel Nathan O, Kathiresan Sekar, Gabriel Stacey, Barrett Jeffrey C, Lehtimäki Terho, Laakso Markku, Groop Leif, Kaprio Jaakko, Perola Markus, McCarthy Mark I, Boehnke Michael, Altshuler David M, Lindgren Cecilia M, Hirschhorn Joel N, Metspalu Andres, Freimer Nelson B, Zeller Tanja, Jalkanen Sirpa, Koskinen Seppo, Raitakari Olli, Durbin Richard, MacArthur Daniel G, Salomaa Veikko, Ripatti Samuli, Daly Mark J, Palotie Aarno, |
|
Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts.
Cardiovascular research 2014 Jul 103 (1): 28-36. Laschkolnig Anja, Kollerits Barbara, Lamina Claudia, Meisinger Christa, Rantner Barbara, Stadler Marietta, Peters Annette, Koenig Wolfgang, Stöckl Andrea, Dähnhardt Doreen, Böger Carsten A, Krämer Bernhard K, Fraedrich Gustav, Strauch Konstantin, Kronenberg Flori |
|
Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohort.
Circulation. Cardiovascular genetics 2014 Jun 7 (3): 304-10. Arsenault Benoit J, Boekholdt S Matthijs, Dubé Marie-Pierre, Rhéaume Eric, Wareham Nicholas J, Khaw Kay-Tee, Sandhu Manjinder S, Tardif Jean-Clau |
|
Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.
Journal of the American College of Cardiology 2014 Feb 63 (5): 470-7. Kamstrup Pia R, Tybjærg-Hansen Anne, Nordestgaard Børge |
|
Effect of CETP polymorphism on atorvastatin lipid-regulating effect and clinical prognosis of patients with coronary heart disease.
Medical science monitor : international medical journal of experimental and clinical research 2014 20 2824-9. Gu Guo-Long, Xu Xiao-Lin, Yang Qing-You, Zeng Ruo-Lo |
|
Genetic variants associated with myocardial infarction and the risk factors in Chinese population.
PloS one 2014 9 (1): e86332. Wang Yongqin, Wang Lefeng, Liu Xin, Zhang Yongzhi, Yu Liping, Zhang Fan, Liu Lisheng, Cai Jun, Yang Xinchun, Wang Xing |
|
LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography.
Lipids in health and disease 2014 13 (1): 74. Santos Paulo Cjl, Bueno Carolina T, Lemos Pedro A, Krieger José E, Pereira Alexandre |
|
The association between the LPA gene polymorphism and coronary artery disease in Chinese Han population.
BioMed research international 2014 2014 370670. Song Zi-Kai, Wu Hai-Di, Cao Hong-Yan, Qin Li |
|
Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery disease.
The American journal of cardiology 2013 Sep 112 (6): 799-804. Anderson Jeffrey L, Knight Stacey, May Heidi T, Horne Benjamin D, Bair Tami L, Huntinghouse John A, Rollo Jeffrey S, Muhlestein Joseph B, Carlquist John |
|
Positive correlation between variants of lipid metabolism?related genes and coronary heart disease.
Molecular medicine reports 2013 Jul 8 (1): 260-6. Zhang Li-Na, Liu Pan-Pan, Zhou Jianqing, Huang R Stephanie, Yuan Fang, Fei Li-Juan, Huang Yi, Xu Limin, Hao Ling-Mei, Qiu Xu-Jun, Le Yanping, Yang Xi, Xu Weifeng, Huang Xiaoyan, Ye Meng, Lian Jiangfang, Duan Shiw |
|
Robust association of the LPA locus with low-density lipoprotein cholesterol lowering response to statin treatment in a meta-analysis of 30 467 individuals from both randomized control trials and observational studies and association with coronary artery disease outcome during statin treatment.
Pharmacogenetics and genomics 2013 Jul . Donnelly LA, van Zuydam NR, Zhou K, Tavendale R, Carr F, Maitland-van der Zee AH, Leusink M, de Boer A, Doevendans PA, Asselbergs FW, Morris AD, Pearson ER, Klungel OH, Doney AS, Palmer CN |
|
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.
European heart journal 2013 Apr 34 (13): 982-92. Hopewell Jemma C, Parish Sarah, Offer Alison, Link Emma, Clarke Robert, Lathrop Mark, Armitage Jane, Collins Rory, |
|
Genetic associations with valvular calcification and aortic stenosis.
The New England journal of medicine 2013 Feb 368 (6): 6. Thanassoulis G, Campbell CY, Owens DS, Smith JG, Smith AV, Peloso GM, Kerr KF, Pechlivanis S, Budoff MJ, Harris TB, Malhotra R, O'Brien KD, Kamstrup PR, Nordestgaard BG, Tybjaerg-Hansen A, Allison MA, Aspelund T, Criqui MH, Heckbert SR, Hwang SJ, Liu Y, Sjogren M, van der Pals J, Kälsch H, Mühleisen TW, Nöthen MM, Cupples LA, Caslake M, Di Angelantonio E, Danesh J, Rotter JI, Sigurdsson S, Wong Q, Erbel R, Kathiresan S, Melander O, Gudnason V, O'Donnell CJ, Post WS |
|
Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction.
Journal of the American College of Cardiology 2013 Jan . Kamstrup PR, Tybjærg-Hansen A, Nordestgaard BG |
|
Two rare variants explain association with acute myocardial infarction in an extended genomic region including the apolipoprotein(a) gene.
Annals of human genetics 2013 Jan 77 (1): 1. Koch W, Mueller JC, Schrempf M, Wolferstetter H, Kirchhofer J, Schömig A, Kastrati A |
|
Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention.
Lipids in health and disease 2013 12 (1): 127. Li Zhi-Gen, Li Guang, Zhou Ying-Ling, Chen Zhu-Jun, Yang Jun-Qing, Zhang Ying, Sun Shuo, Zhong Shi-Lo |
|
HIV Disease Activity as a Modulator of Lipoprotein(a) and Allele-Specific Apolipoprotein(a) Levels.
Arteriosclerosis, thrombosis, and vascular biology 2012 Nov . Enkhmaa B, Anuurad E, Zhang W, Abbuthalha A, Li XD, Dotterweich W, Pollard RB, Asmuth DM, Berglund L |
|
Lack of association between four SNPs in the SLC22A3-LPAL2-LPA gene cluster and coronary artery disease in a Chinese Han population: a case control study.
Lipids in health and disease 2012 Oct 11 (1): 1. Lv X, Qiu J, Rao S, Zhang Y, Wang M, Liu F, Su D, Zuo X, Feng X, Xia M, Feng D, Yang Y, Ouyang P, Ling W, Ma W, Guo H, Li X, Li D |
|
Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism.
Journal of the American College of Cardiology 2012 Aug 60 (8): 722-9. Helgadottir Anna, Gretarsdottir Solveig, Thorleifsson Gudmar, Holm Hilma, Patel Riyaz S, Gudnason Thorarinn, Jones Gregory T, van Rij Andre M, Eapen Danny J, Baas Annette F, Tregouet David-Alexandre, Morange Pierre-Emmanuel, Emmerich Joseph, Lindblad Bengt, Gottsäter Anders, Kiemeny Lambertus A, Lindholt Jes S, Sakalihasan Natzi, Ferrell Robert E, Carey David J, Elmore James R, Tsao Philip S, Grarup Niels, Jørgensen Torben, Witte Daniel R, Hansen Torben, Pedersen Oluf, Pola Roberto, Gaetani Eleonora, Magnadottir Hulda B, Wijmenga Cisca, Tromp Gerard, Ronkainen Antti, Ruigrok Ynte M, Blankensteijn Jan D, Mueller Thomas, Wells Philip S, Corral Javier, Soria Jose Manuel, Souto Juan Carlos, Peden John F, Jalilzadeh Shapour, Mayosi Bongani M, Keavney Bernard, Strawbridge Rona J, Sabater-Lleal Maria, Gertow Karl, Baldassarre Damiano, Nyyssönen Kristiina, Rauramaa Rainer, Smit Andries J, Mannarino Elmo, Giral Philippe, Tremoli Elena, de Faire Ulf, Humphries Steve E, Hamsten Anders, Haraldsdottir Vilhelmina, Olafsson Isleifur, Magnusson Magnus K, Samani Nilesh J, Levey Allan I, Markus Hugh S, Kostulas Konstantinos, Dichgans Martin, Berger Klaus, Kuhlenbäumer Gregor, Ringelstein E Bernd, Stoll Monika, Seedorf Udo, Rothwell Peter M, Powell Janet T, Kuivaniemi Helena, Onundarson Pall T, Valdimarsson Einar, Matthiasson Stefan E, Gudbjartsson Daniel F, Thorgeirsson Guðmundur, Quyyumi Arshed A, Watkins Hugh, Farrall Martin, Thorsteinsdottir Unnur, Stefansson Ka |
|
Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a).
Journal of lipid research 2012 May 53 (5): 1000-11. Deshmukh Harshal A, Colhoun Helen M, Johnson Toby, McKeigue Paul M, Betteridge D John, Durrington Paul N, Fuller John H, Livingstone Shona, Charlton-Menys Valentine, Neil Andrew, Poulter Neil, Sever Peter, Shields Denis C, Stanton Alice V, Chatterjee Aurobindo, Hyde Craig, Calle Roberto A, Demicco David A, Trompet Stella, Postmus Iris, Ford Ian, Jukema J Wouter, Caulfield Mark, Hitman Graham A, |
|
Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.
Circulation. Cardiovascular genetics 2012 Apr 5 (2): 257-64. Chasman Daniel I, Giulianini Franco, MacFadyen Jean, Barratt Bryan J, Nyberg Fredrik, Ridker Paul |
|
Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes.
European heart journal 2012 Feb 33 (3): 325-34. Qi Qibin, Workalemahu Tsegaselassie, Zhang Cuilin, Hu Frank B, Qi |
|
Pharmacogenetic determinants of statin-induced reductions in C-reactive protein.
Circulation. Cardiovascular genetics 2012 Feb 5 (1): 58-65. Chu Audrey Y, Guilianini Franco, Barratt Bryan J, Nyberg Fredrik, Chasman Daniel I, Ridker Paul |
|
KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly.
Atherosclerosis 2011 Dec . Akao H, Polisecki E, Kajinami K, Trompet S, Robertson M, Ford I, Jukema JW, de Craen AJ, Westendorp RG, Shepherd J, Packard C, Buckley BM, Schaefer EJ |
|
Large-scale gene-centric analysis identifies novel variants for coronary artery disease.
PLoS genetics 2011 Sep 7 (9): e1002260. Authors are not available |
|
Genetic and clinical correlates of early-outgrowth colony-forming units.
Circulation. Cardiovascular genetics 2011 Jun 4 (3): 296-304. Shaw Stanley Y, Cheng Susan, Cupples L Adrienne, Larson Martin G, McCabe Elizabeth L, Ngwa Julius S, Wang Ying A, Martin Roderick P, Klein Rachael J, Hashmi Basma, Ajijola Olujimi A, Lau Evan, O'Donnell Christopher J, Vasan Ramachandran S, Cohen Kenneth S, Wang Thomas |
|
Evaluation of how gene-job strain interaction affects blood pressure in the PAMELA study.
Psychosomatic medicine 2011 May 73 (4): 304-9. Menni Cristina, Bagnardi Vincenzo, Padmanabhan Sandosh, Facchetti Rita, Sega Roberto, Ferrario Marco M, Brambilla Paolo, Lee Wai K, Dominiczak Anna F, Mancia Giuseppe, Cesana Giancar |
|
Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality.
Scandinavian journal of clinical and laboratory investigation 2011 Apr 71 (2): 87-93. Kamstrup Pia R, Tybjærg-Hansen Anne, Nordestgaard Børge |
|
Genetic risk score and risk of myocardial infarction in Hispanics.
Circulation 2011 Feb 123 (4): 374-80. Qi Lu, Ma Jiantao, Qi Qibin, Hartiala Jaana, Allayee Hooman, Campos Hann |
|
Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study.
Circulation. Cardiovascular genetics 2011 Feb 4 (1): 68-73. Hopewell Jemma C, Clarke Robert, Parish Sarah, Armitage Jane, Lathrop Mark, Hager Jorg, Collins Rory, |
|
Genetic variation in LPAL2, LPA, and PLG predicts plasma lipoprotein(a) level and carotid artery disease risk.
Stroke; a journal of cerebral circulation 2011 Jan 42 (1): 2-9. Ronald James, Rajagopalan Ramakrishnan, Cerrato Felecia, Nord Alex S, Hatsukami Thomas, Kohler Ted, Marcovina Santica, Heagerty Patrick, Jarvik Gail |
|
Geographic differences in allele frequencies of susceptibility SNPs for cardiovascular disease.
BMC medical genetics 2011 12 55. Ding Keyue, Kullo Iftikhar |
|
Large-scale candidate gene analysis of HDL particle features.
PloS one 2011 6 (1): e14529. Kaess Bernhard M, Tomaszewski Maciej, Braund Peter S, Stark Klaus, Rafelt Suzanne, Fischer Marcus, Hardwick Robert, Nelson Christopher P, Debiec Radoslaw, Huber Fritz, Kremer Werner, Kalbitzer Hans Robert, Rose Lynda M, Chasman Daniel I, Hopewell Jemma, Clarke Robert, Burton Paul R, Tobin Martin D, Hengstenberg Christian, Samani Nilesh |
|
Single-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans.
PloS one 2011 6 (1): e14581. Deo Rahul C, Wilson James G, Xing Chao, Lawson Kim, Kao W H Linda, Reich David, Tandon Arti, Akylbekova Ermeg, Patterson Nick, Mosley Thomas H, Boerwinkle Eric, Taylor Herman |
|
Hemostatic gene polymorphisms in young Sardinian with non-fatal acute myocardial infarction.
Frontiers in bioscience (Elite edition) 2010 2 . Musino L, Rossi R, Partenza A, Mureddu G, Zinellu A, Pilo P, Maoddi I, Spazzafumo L, Franconi F, Deiana L, Carru C |
|
A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses.
Lancet (London, England) 2010 Oct 376 (9750): 1393-400. Ripatti Samuli, Tikkanen Emmi, Orho-Melander Marju, Havulinna Aki S, Silander Kaisa, Sharma Amitabh, Guiducci Candace, Perola Markus, Jula Antti, Sinisalo Juha, Lokki Marja-Liisa, Nieminen Markku S, Melander Olle, Salomaa Veikko, Peltonen Leena, Kathiresan Sek |
|
Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy.
Journal of lipid research 2010 Oct 51 (10): 3055-61. Nicholls Stephen J, Tang W H Wilson, Scoffone Heather, Brennan Danielle M, Hartiala Jaana, Allayee Hooman, Hazen Stanley |
|
Single variants can explain the association between coronary heart disease and haplotypes in the apolipoprotein(a) locus.
Atherosclerosis 2010 Sep 212 (1): 193-6. Shiffman Dov, Louie Judy Z, Rowland Charles M, Malloy Mary J, Kane John P, Devlin James |
|
The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles.
Atherosclerosis 2010 Apr 209 (2): 498-503. Arai Kiyohito, Luke May M, Koschinsky Marlys L, Miller Elizabeth R, Pullinger Clive R, Witztum Joseph L, Kane John P, Tsimikas Sotiri |
|
Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
The New England journal of medicine 2009 Dec 361 (26): 26. Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, Heath SC, Parish S, Barlera S, Franzosi MG, Rust S, Bennett D, Silveira A, Malarstig A, Green FR, Lathrop M, Gigante B, Leander K, de Faire U, Seedorf U, Hamsten A, Collins R, Watkins H, Farrall M |
|
Integrative predictive model of coronary artery calcification in atherosclerosis.
Circulation 2009 Dec 120 (24): 2448-54. McGeachie Michael, Ramoni Rachel L Badovinac, Mychaleckyj Josyf C, Furie Karen L, Dreyfuss Jonathan M, Liu Yongmei, Herrington David, Guo Xiuqing, Lima João A, Post Wendy, Rotter Jerome I, Rich Stephen, Sale Michèle, Ramoni Marco |
|
Lipid profiles and associated gene polymorphisms in young Asian Indian patients with acute myocardial infarction and the metabolic syndrome.
Metabolic syndrome and related disorders 2009 Dec 7 (6): 571-8. Ranjith Naresh, Pegoraro Rosemary J, Rom L |
|
Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.
American journal of human genetics 2009 Nov 85 (5): 628-42. Talmud Philippa J, Drenos Fotios, Shah Sonia, Shah Tina, Palmen Jutta, Verzilli Claudio, Gaunt Tom R, Pallas Jacky, Lovering Ruth, Li Kawah, Casas Juan Pablo, Sofat Reecha, Kumari Meena, Rodriguez Santiago, Johnson Toby, Newhouse Stephen J, Dominiczak Anna, Samani Nilesh J, Caulfield Mark, Sever Peter, Stanton Alice, Shields Denis C, Padmanabhan Sandosh, Melander Olle, Hastie Claire, Delles Christian, Ebrahim Shah, Marmot Michael G, Smith George Davey, Lawlor Debbie A, Munroe Patricia B, Day Ian N, Kivimaki Mika, Whittaker John, Humphries Steve E, Hingorani Aroon D, , , |
|
Decrease of Lp(a) during weight reduction in obese children is modified by the apo(a) kringle-IV copy number variation.
International journal of obesity (2005) 2009 Oct 33 (10): 1136-42. Brandstätter A, Lingenhel A, Zwiauer K, Strobl W, Kronenberg |
|
Phenotype-genotype interactions on renal function in type 2 diabetes: an analysis using structural equation modelling.
Diabetologia 2009 Aug 52 (8): 1543-53. Song X Y, Lee S Y, Ma R C W, So W Y, Cai J H, Tam C, Lam V, Ying W, Ng M C Y, Chan J C |
|
A field synopsis and meta-analysis of genetic association studies in peripheral arterial disease: The CUMAGAS-PAD database.
American journal of epidemiology 2009 Jul 170 (1): 1-11. Zintzaras Elias, Zdoukopoulos Nik |
|
Coronary heart disease risk, aspirin use, and apolipoprotein(a) 4399Met allele in the Atherosclerosis Risk in Communities (ARIC) study.
Thrombosis and haemostasis 2009 Jul 102 (1): 179-80. Shiffman Dov, Chasman Daniel I, Ballantyne Christie M, Nambi Vijay, Devlin James J, Boerwinkle Er |
|
Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach.
Clinica chimica acta; international journal of clinical chemistry 2009 Apr 402 (1-2): 189-92. Zee Robert Y L, Bubes Vadim, Shrivastava Sanjay, Ridker Paul M, Glynn Robert |
|
Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy.
Atherosclerosis 2009 Apr 203 (2): 371-6. Chasman Daniel I, Shiffman Dov, Zee Robert Y L, Louie Judy Z, Luke May M, Rowland Charles M, Catanese Joseph J, Buring Julie E, Devlin James J, Ridker Paul |
|
A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients.
Stroke; a journal of cerebral circulation 2009 Mar 40 (3): 683-95. Wang Xingyu, Cheng Suzanne, Brophy Victoria H, Erlich Henry A, Mannhalter Christine, Berger Klaus, Lalouschek Wolfgang, Browner Warren S, Shi Yu, Ringelstein E Bernd, Kessler Christof, Luedemann Jan, Lindpaintner Klaus, Liu Lisheng, Ridker Paul M, Zee Robert Y L, Cook Nancy R, |
|
Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease.
Nature genetics 2009 Mar 41 (3): 283-5. Trégouët David-Alexandre, König Inke R, Erdmann Jeanette, Munteanu Alexandru, Braund Peter S, Hall Alistair S, Grosshennig Anika, Linsel-Nitschke Patrick, Perret Claire, DeSuremain Maylis, Meitinger Thomas, Wright Ben J, Preuss Michael, Balmforth Anthony J, Ball Stephen G, Meisinger Christa, Germain Cécile, Evans Alun, Arveiler Dominique, Luc Gérald, Ruidavets Jean-Bernard, Morrison Caroline, van der Harst Pim, Schreiber Stefan, Neureuther Katharina, Schäfer Arne, Bugert Peter, El Mokhtari Nour E, Schrezenmeir Jürgen, Stark Klaus, Rubin Diana, Wichmann H-Erich, Hengstenberg Christian, Ouwehand Willem, , , Ziegler Andreas, Tiret Laurence, Thompson John R, Cambien Francois, Schunkert Heribert, Samani Nilesh |
|
Gene variants associated with ischemic stroke: the cardiovascular health study.
Stroke; a journal of cerebral circulation 2009 Feb 40 (2): 363-8. Luke May M, O'Meara Ellen S, Rowland Charles M, Shiffman Dov, Bare Lance A, Arellano Andre R, Longstreth W T, Lumley Thomas, Rice Kenneth, Tracy Russell P, Devlin James J, Psaty Bruce |
|
Single nucleotide polymorphisms in the apo(a) kringle IV type 8 domain are not associated with atherothrombotic serum lipoprotein (a) concentration, in a Portuguese paediatric population.
International journal of laboratory hematology 2008 Jun 30 (3): 240-3. Ferreira H, Costa E, Vieira E, Barbot J, Dos Santos |
|
Analysis of polymorphisms in the 5'-flanking region of the apolipoprotein(a) [Apo(a)] gene in Thai subjects with coronary artery diseases.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2008 Jan 91 (1): 86-92. Tirawanchai Nednapis, Leowattana Wattana, Somkasetrin Anchaleekorn, Thongsaen Pushd |
|
Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study.
Arteriosclerosis, thrombosis, and vascular biology 2008 Jan 28 (1): 173-9. Shiffman Dov, O'Meara Ellen S, Bare Lance A, Rowland Charles M, Louie Judy Z, Arellano Andre R, Lumley Thomas, Rice Kenneth, Iakoubova Olga, Luke May M, Young Bradford A, Malloy Mary J, Kane John P, Ellis Stephen G, Tracy Russell P, Devlin James J, Psaty Bruce |
|
The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease.
Clinica chimica acta; international journal of clinical chemistry 2008 Jan 387 (1-2): 109-12. Catalano Mariella, Cortelazzo Adriano, Yilmaz Yusuf, Perilli Edoardo, Carzaniga Gianni, Emanuele En |
|
Analysis of 17,576 potentially functional SNPs in three case-control studies of myocardial infarction.
PloS one 2008 3 (8): e2895. Shiffman Dov, Kane John P, Louie Judy Z, Arellano Andre R, Ross David A, Catanese Joseph J, Malloy Mary J, Ellis Stephen G, Devlin James |
|
Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease.
Lipids in health and disease 2008 7 (1): 46. Bahri Raoudha, Esteban Esther, Moral Pedro, Hassine Mohsen, Ben Hamda Khaldoun, Chaabani Hass |
|
A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease.
Arteriosclerosis, thrombosis, and vascular biology 2007 Sep 27 (9): 2030-6. Luke May M, Kane John P, Liu Dongming M, Rowland Charles M, Shiffman Dov, Cassano June, Catanese Joseph J, Pullinger Clive R, Leong Diane U, Arellano Andre R, Tong Carmen H, Movsesyan Irina, Naya-Vigne Josephina, Noordhof Curtis, Feric Nicole T, Malloy Mary J, Topol Eric J, Koschinsky Marlys L, Devlin James J, Ellis Stephen |
|
Apolipoprotein(a) gene polymorphisms (TTTTA)n and G/A-914 affect Lp(a) levels in ischemic heart disease patients from Serbia.
Wiener klinische Wochenschrift 2005 Jun 117 (11-12): 406-11. Dinci? Dragan, Zivkovi? Maja, Stankovi? Aleksandra, Djuri? Tamara, Vujani? Svetlana, Gligi? Branko, Alavanti? Drag |
|
Molecular variation at functional genes and the history of human populations--data on candidate genes for cardiovascular risk in the Mediterranean.
Collegium antropologicum 2003 Dec 27 (2): 523-36. Moral Pedro, Valveny Neus, López-Alomar Antonio, Calo Carla, Kandil Mostafa, Harich Nordin, González-Pérez Emili, Via Marc, Esteban Esther, Dugoujon Jean Michel, Vona Giusep |
|
Association of polymorphisms of the apolipoprotein(a) gene with lipoprotein(a) levels and myocardial infarction.
Circulation 2003 Feb 107 (5): 696-701. Holmer Stephan R, Hengstenberg Christian, Kraft Hans-Georg, Mayer Björn, Pöll Melanie, Kürzinger Susanne, Fischer Marcus, Löwel Hannelore, Klein Gernot, Riegger Günter A J, Schunkert Heribe |
|
APO(a) variants and lipoprotein(a) in men with or without myocardial infarction.
Experimental and molecular pathology 2002 Aug 73 (1): 28-34. Chimienti Guglielmina, Lamanuzzi Biagia L, Nardulli Marina, Colacicco Anna M, Capurso Antonio, La Gioia Rocco, Scrutinio Domenico, Pepe Gabriel |
|
Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex disease.
The pharmacogenomics journal 2002 2 (3): 197-201. Zee R Y L, Hoh J, Cheng S, Reynolds R, Grow M A, Silbergleit A, Walker K, Steiner L, Zangenberg G, Fernandez-Ortiz A, Macaya C, Pintor E, Fernandez-Cruz A, Ott J, Lindpainter |
|
Genetic evaluation of lipoprotein(a) in intracranial aneurysm disease.
Neurosurgery 2001 Jul 49 (1): 133-40; discussion 141-2. Roberts G A, Corcoran B T, Pfouts L L, Phillips J P, Farrell M A, Bouchier-Hayes D J, Collins P |
|
Polymorphisms in human apolipoprotein(a) kringle IV-10 and coronary artery disease: relationship to allele size, plasma lipoprotein(a) concentration, and lysine binding site activity.
Journal of molecular medicine (Berlin, Germany) 2001 Jun 79 (5-6): 294-9. Simó JM, Joven J, Vilella E, Ribas M, Figuera L, Virgos C, Sundaram IM, Hoover-Plow J |
|
Apolipoprotein A polymorphisms and plasma lipoprotein(a) concentrations in non-Hispanic Whites and Hispanics.
Human biology 2000 Oct 72 (5): 821-35. Chiu L, Hamman R F, Kamboh M |
|
Lp(a) and apoE polymorphisms in young South African Indians with myocardial infarction.
Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 0 15 (3): 111-7. Ranjith N, Pegoraro R J, Rom L, Rajput M C, Naidoo D |
- Page last reviewed:Mar 1, 2018
- Page last updated:Jun 20, 2019
- Content source: